Gilead’s Matthew Sause to Join Roche Diagnostics as North America CEO

Roche Diagnostics has appointed Matthew Sause to serve as president and CEO of its North America operations. Sause is coming to Indianapolis-based Roche Diagnostics from Gilead Sciences (NASDAQ: [[ticker:GILD]]), where he is senior vice president and head of global commercial product. His experience includes 17 years at Roche, including time at the company’s diagnostics division. Sause is scheduled to start his new role at Roche Diagnostics on Nov. 4. He will succeed Jack Phillips, who left the company at the end of August.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan